Angioplasty and stenting of atherosclerotic middle cerebral arteries with wingspan: Evaluation of clinical outcome, restenosis, and procedure outcome

American Journal of Neuroradiology

Volumn 32, Issue 4, 2011, Pages 753-758

  Yu, Simon Chun Ho ^a   Leung, T W H ^a   Lee, K T ^a   Hui, J W Y ^a   Wong, L K S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

IOPAMIDOL; IOPAMIRAL; NITINOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY DIAMETER; ARTERY DISSECTION; ARTERY PERFORATION; ARTICLE; BARE METAL STENT; BRAIN ATHEROSCLEROSIS; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; IN-STENT RESTENOSIS; MALE; MIDDLE CEREBRAL ARTERY; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIOPERATIVE COMPLICATION; STROKE; SURGICAL MORTALITY; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; CEREBRAL ANGIOGRAPHY; CEREBRAL REVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 79954467913     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2363     Document Type: Article

References (20)

1. Bogousslavsky J, Barnett HJ, Fox AJ, et al. Atherosclerotic disease of the middle cerebral artery. Stroke 1986;17:1112-20 (Pubitemid 17008939)
2. Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45:1488-93
3. Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000;55:490-97 (Pubitemid 30647243)
4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305-16
5. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial - The EC/IC Bypass Study Group. N Engl J Med 1985;313:1191-200
6. Rundek T, Elkind MS, Chen X. Increased early stroke recurrence among patients with extracranial and intracranial atherosclerosis: Northern Manhattan Stroke Study. Neurology 1998;50(suppl 4):A75
7. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 1998;29:1389-92
8. Caplan LR. Advances in stroke research: basic science, treatment, and clinical trial outcomes. Rev Neurol Dis 2004;2:91-94
9. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-63
10. Qureshi AI, Feldmann E, Gomez CR, et al. Consensus conference on intracranial atherosclerotic disease: rationale, methodology, and results. J Neuroimaging 2009;19(suppl 1):1S-10S
11. Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016-20
12. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007;38:1531-37 (Pubitemid 46684170)
13. Mori T, Fukuoka M, Kazita K, et al. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol 1998;19:1525-33 (Pubitemid 30431049)
14. Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643-46 (Pubitemid 30210425)
15. Levy EI, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007;61:644-51
16. Albuquerque FC, Levy EI, Turk AS, et al. Angiographic patterns of Wingspan in-stent restenosis. Neurosurgery 2008;63:23-27
17. Turk AS, Levy EI, Albuquerque FC, et al. Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008;29:23-27
18. Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881-87 (Pubitemid 46568447)
19. Zaidat OO, Klucznik R, Alexander MJ, et al, for the NIH Multi-Center Wingspan Intracranial Stent Registry Study Group. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008;70:1518-24 (Pubitemid 351589505)
20. Nahab F, Lynn MJ, Kasner SE, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009;72:2014-19